Dr. Stevens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
267 W Hillcrest Dr
Thousand Oaks, CA 91360Phone+1 805-497-1694Fax+1 805-373-7493
Education & Training
University of MichiganResidency, Dermatology, 1990 - 1993
Oregon Health & Science University (OHSU Health)Residency, Surgery, 1986 - 1988
Oregon Health and Science University School of MedicineClass of 1986
Certifications & Licensure
OR State Medical License 1987 - Present
CA State Medical License 2008 - 2026
OH State Medical License 1995 - 2018
MI State Medical License 1990 - 1997
WA State Medical License 1989 - 1990- American Board of Dermatology Dermatology
- American Board of Dermatology Clinical & Laboratory Dermatological Immunology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 17 citationsPhase I Clinical Trial of O6-Benzylguanine and Topical Carmustine in the Treatment of Cutaneous T-Cell Lymphoma, Mycosis Fungoides TypeNarin Apisarnthanarax, Gary S. Wood, Seth R. Stevens, Sean Carlson, Derek V. Chan
Archives of Dermatology. 2012-05-01 - 25 citationsA retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept.Sejal K. Shah, Angele Arthur, Yu-Ching Yang, Seth Stevens, Andrew F Alexis
Journal of Drugs in Dermatology. 2011-08-01 - 18 citationsPreliminary Clinical and Pharmacologic Investigation of Photodynamic Therapy with the Silicon Phthalocyanine Photosensitizer Pc 4 for Primary or Metastatic Cutaneous C...Timothy J. Kinsella, Elma D. Baron, Valdir C. Colussi, Kevin D. Cooper, Charles L. Hoppel
Frontiers in Oncology. 2011-06-30
Grant Support
- Core--Translational ResearchNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2002
- T Cell Activiation By Distinct Antigen Presenting CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
- Treatment Of CTCL With O6 Benzylguanine/BcnuNational Cancer Institute1998–1999
- Distinct T Cell Activation By Antigen Presenting CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998
- Pilot--T-Cell Activation By Uv-Exposed And Normal Skin CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
